Cargando…

3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Cong, Mengqing, Yang, Yunru, Tong, Haiyang, Shimu, Ajmeri Sultana, Wang, Baolong, Li, Qing, Li, Fengyin, Yang, Yi, Jin, Tengchuan, Li, Bofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918896/ https://www.ncbi.nlm.nih.gov/pubmed/35288536 http://dx.doi.org/10.1038/s41392-022-00937-9

Ejemplares similares

The new progress in cancer immunotherapy
por: Shimu, Ajmeri Sultana, et al.
Publicado: (2022)

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
por: Chen, Yu-Lei, et al.
Publicado: (2022)

RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2
por: Meena, Jairam, et al.
Publicado: (2022)

Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity
por: Zahid, Ayesha, et al.
Publicado: (2020)

A comparative study of biological potentiality and EAC cell growth inhibition activity of Phyllanthus acidus (L.) fruit pulp and seed in Bangladesh
por: Shimu, Ajmeri Sultana, et al.
Publicado: (2021)

Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
por: Westcott, Peter M. K., et al.
Publicado: (2023)

Methanolic Bark Extract of Abroma augusta (L.) Induces Apoptosis in EAC Cells through Altered Expression of Apoptosis Regulatory Genes
por: Miah, Masum, et al.
Publicado: (2020)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
por: Tian, Siyu, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice
por: Love, J., et al.
Publicado: (2023)

SARS-CoV-2 molecular identification and clinical data analysis of associated risk factors from a COVID-19 testing laboratory of a coastal region in Bangladesh
por: Ali, Md Roushan, et al.
Publicado: (2021)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain
por: Wu, Jiajing, et al.
Publicado: (2022)

IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
por: Wei, Hua-Xing, et al.
Publicado: (2020)

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
por: Pan, Xiaoyan, et al.
Publicado: (2021)

Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
por: Indenbaum, Victoria, et al.
Publicado: (2020)

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
por: Liang, Qingtai, et al.
Publicado: (2022)

A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants
por: Liu, Yu, et al.
Publicado: (2022)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
por: Chen, Yuxin, et al.
Publicado: (2021)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Molecular and structural aspects of gasdermin family pores and insights into gasdermin-elicited programmed cell death
por: Zahid, Ayesha, et al.
Publicado: (2021)

Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
por: Sokal, Aurélien, et al.
Publicado: (2022)

Memory impairment is not sufficient for choice blindness to occur
por: Sagana, Anna, et al.
Publicado: (2014)

Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice
por: Ke, Qian, et al.
Publicado: (2022)

Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
por: Li, Letian, et al.
Publicado: (2021)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Are single odorous components of a predator sufficient to elicit defensive behaviors in prey species?
por: Apfelbach, Raimund, et al.
Publicado: (2015)

Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8(+) T cells
por: Maurice, Nicholas J., et al.
Publicado: (2021)

Prostaglandin production selectively in brain endothelial cells is both necessary and sufficient for eliciting fever
por: Shionoya, Kiseko, et al.
Publicado: (2022)

A Necessary and Sufficient Criterion for the Separability of Quantum State
por: Li, Jun-Li, et al.
Publicado: (2018)

Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine
por: Li, Chia-Jung, et al.
Publicado: (2023)

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
por: Sun, Wenqiang, et al.
Publicado: (2021)

Brain stimulation and elicited memories
por: Sjöberg, Rickard L.
Publicado: (2022)

Isolated face features are sufficient to elicit ultra-rapid and involuntary orienting responses toward faces
por: Kauffmann, Louise, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains
por: Zhang, Ye, et al.
Publicado: (2022)

SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023)

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
por: Ma, Xiancai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5t8biou26fh4d1q1gti35o7ilf